32 Spam-Free Article(s) Found
Sort:
Date
Filter:
All
Article Searches
BDX upped to buy by Citi, TNDM put on Negative Catalyst Watch https://seekingalpha.com/news/4155278-bdx-upped-to-buy-by-citi-tndm-put-on-negative-catalyst-watch?source=feed_sector_healthcare Oct 01, 2024 - Citi upgrades Becton Dickinson (BDX) to buy, puts Tandem (TNDM) on a Negative Catalyst Watch and maintains a Positive Catalyst Watch on Edwards Lifesciences (EW). Read more here.
Medtronic Keeps Capturing High-Growth Markets: Time to Buy MDT Stock? https://www.zacks.com/stock/news/2334726/medtronic-keeps-capturing-high-growth-markets-time-to-buy-mdt-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2334726 Sep 11, 2024 - MDT stock breaking above its 200 and 50-day SMAs can be a piece of good news for investors, signaling an uptrend.
With HOLX Stock Near 52-Week High, Should You Buy More or Play Safe? https://www.zacks.com/stock/news/2332675/with-holx-stock-near-52-week-high-should-you-buy-more-or-play-safe?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2332675 Sep 06, 2024 - Hologic's business diversification holds strong potential internationally. Also, its discounted valuation makes it attractive from an investment perspective.
Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term https://www.zacks.com/stock/news/2326300/why-becton-dickinson-bdx-is-a-top-growth-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_growth_score-2326300 Aug 23, 2024 - Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term https://www.zacks.com/stock/news/2325628/why-becton-dickinson-bdx-is-a-top-value-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_value_score-2325628 Aug 22, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term https://www.zacks.com/stock/news/2324992/why-becton-dickinson-bdx-is-a-top-momentum-stock-for-the-long-term?cid=CS-ZC-FT-tale_of_the_tape|zacks_education_momentum_score-2324992 Aug 21, 2024 - The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
Abbott Up 7.7% Post Q2 Earnings: Should You Buy ABT Stock? https://www.zacks.com/stock/news/2321482/abbott-up-7-7-post-q2-earnings-should-you-buy-abt-stock?cid=CS-ZC-FT-analyst_blog|most_popular_stocks-2321482 Aug 13, 2024 - Abbott's (ABT) strong growth projection for 2024 is an indication that the stock will be able to sustain the positive momentum through the rest of the year.
Conmed (CNMD) Q2 Earnings Beat Estimates https://www.zacks.com/stock/news/2313564/conmed-cnmd-q2-earnings-beat-estimates?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_4-2313564 Jul 31, 2024 - Conmed (CNMD) delivered earnings and revenue surprises of 6.52% and 0.74%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
What Makes Becton Dickinson (BDX) a New Buy Stock https://www.zacks.com/stock/news/2307167/what-makes-becton-dickinson-bdx-a-new-buy-stock?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_12_zacks_rank_upgrade-2307167 Jul 23, 2024 - Becton Dickinson (BDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
BDX vs. MMSI: Which Stock Should Value Investors Buy Now? https://www.zacks.com/stock/news/2307125/bdx-vs-mmsi-which-stock-should-value-investors-buy-now?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2307125 Jul 23, 2024 - BDX vs. MMSI: Which Stock Is the Better Value Option?

Pages: 1234

Page 1>